India Needs To Expand Local Vaccine Manufacturing, Research: GTRI Report

New Delhi:  India needs to expand its local vaccine manufacturing and research to give better control over safety of these pharma products, think tank GTRI said on Monday.

The Global Trade Research Initiative (GTRI) also suggested the government launch an investigation to track all adverse health events post-vaccination as this could help make future vaccine rollouts more transparent, safe and effective.

“Expanding local vaccine manufacturing and research can give India better control over vaccine safety, ensuring vaccines meet local needs and are tailored to the population’s health characteristics,” it said in a report.

It added that these suggestions assume importance in the backdrop of the October 2024 release of “The Pfizer Papers: Crimes Against Humanity” which has ignited global debate over vaccine safety, ethics and transparency.

“As the world prepares for future pandemics, the insights from The Pfizer Papers provide a foundation for building safer, more effective and more trustworthy vaccination strategies, ensuring public health is prioritised over profit in global health responses,” GTRI Founder Ajay Srivastava said.

Related Posts

  • Pharma
  • July 16, 2025
  • 125 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 39 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.